Free CME from PeerView


Psychiatry CME

Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Translating the Latest Research Advances Into Routine Care for Alzheimer’s Disease: Preparing Dementia Specialists With the Latest Strategies to Support Early Diagnosis and Comprehensive Care
Marwan Sabbagh, MD, FAAN
January 17, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Revealing the Neuropathology of Alzheimer’s Disease Through Novel Fluid and Imaging Biomarkers: Ushering in a Precision Era of Diagnosis and Treatment
Val J. Lowe, MD / Jonathan E. McConathy, MD, PhD
November 28, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Therapeutic Advances in the Early Treatment of Alzheimer’s Disease: Expert Insights on Novel Biomarkers and Emerging Disease-Modifying Therapies
David Weidman, MD
June 20, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
Applying Evidence to Practice in Postpartum Depression: Expert Guidance on Integrating Therapeutic Innovations and Shared Decision-Making Strategies to Optimize Patient Care
Kristina M. Deligiannidis, MD
April 08, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Recent Advances in the Management of Depressive Disorders: Preparing for a Shift in the Treatment Paradigm
Anita H. Clayton, MD
March 31, 2022
Credits: 2.0 CME / MOC
Purdue University
Accelerating Progress in the Treatment of Alzheimer’s Disease: How Can We Achieve Timely and Accurate Neuropathological Diagnosis and Precision Management of Mild Cognitive Impairment in Early Alzheimer’s Disease?
Liana G. Apostolova, MS, MD, FAAN
March 18, 2022
Credits: 0.5 CME / NCPD
American Psychiatric Nurses Association
Addressing Unmet Needs in the Management of Schizophrenia and Bipolar Disorder: New and Emerging Therapeutic Options to Enhance Treatment and Maximize Patient Outcomes
Alan "Tony" Amberg, APRN, PMHNP-BC
February 04, 2022
Medical Learning Institute, Inc.
Recent Advances and Novel Options in Depression: Reviewing the Evidence for GABA-Modulating Neuroactive Steroids for Major Depressive Disorder
Anita H. Clayton, MD
December 31, 2021
Heart Failure Society of America
Easing the Burden of Hypertrophic Cardiomyopathy: Progress in Understanding and Addressing Its Pathophysiology
Daniel Jacoby, MD
October 01, 2021
Medical Learning Institute, Inc.
Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
Donna H. Ryan, MD, FTOS
July 15, 2021
Medical Learning Institute, Inc.
The Dawn of a New Era: Recent Advances in the Pharmacologic Management of Idiopathic Hypersomnia
R. Robert Auger, MD, FAASM, FAPA, DABPN
June 25, 2021
Medical Learning Institute, Inc.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
Richard K. Bogan, MD, FCCP, FAASM
May 18, 2021
Medical Learning Institute, Inc.
Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
Karl E. Anderson, MD
April 15, 2021
Penn State College of Medicine
Test Your Knowledge: The Evidence for GABA-Modulating Neuroactive Steroids as a New Class of Rapid-Acting Antidepressants
Kristina M. Deligiannidis, MD
March 16, 2021

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView